AstraZeneca has welcomed a new registration for its asthma therapies SYMBICORT TURBUHALER and SYMBICORT RAPIHALER (budesonide and formoterol) and will be hoping for a positive outcome at November's PBAC meeting. …
Latest Video
New Stories
-
Endometriosis diagnoses in Australian GP clinics Nearly double over a decade
October 21, 2025 - -
'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'
October 21, 2025 - - Latest News -
Vaccine confidence slips as Australians grow more concerned about access to healthcare
October 20, 2025 - - Latest News -
NZ's Pharmac proposes new rules to manage 'Options for Investment' list - make it shorter
October 20, 2025 - - Latest News -
Monash scientists crack genetic ‘code’ behind RNA splicing, opening door to to new therapies
October 20, 2025 - - Australian Biotech -
Radiopharm secures funding to accelerate radiopharmaceutical pipeline as data show strong momentum
October 20, 2025 - - Australian Biotech -
Neuren secures FDA 'Fast Track Designation' for NNZ-2591 in Phelan-McDermid Syndrome
October 20, 2025 - - Australian Biotech